Versor Investments LP acquired a new position in shares of Dolby Laboratories (NYSE:DLB - Free Report) in the 1st quarter, according to its most recent filing with the SEC. The fund acquired 22,087 shares of the electronics maker's stock, valued at approximately $1,774,000.
A number of other large investors have also made changes to their positions in DLB. Alpine Bank Wealth Management acquired a new stake in Dolby Laboratories during the first quarter worth $25,000. Cheviot Value Management LLC acquired a new position in Dolby Laboratories during the first quarter worth $27,000. Caitong International Asset Management Co. Ltd acquired a new position in Dolby Laboratories during the first quarter worth $29,000. Global X Japan Co. Ltd. acquired a new position in Dolby Laboratories during the first quarter worth $51,000. Finally, Fifth Third Bancorp lifted its stake in Dolby Laboratories by 84.7% during the first quarter. Fifth Third Bancorp now owns 665 shares of the electronics maker's stock worth $53,000 after purchasing an additional 305 shares in the last quarter. 58.56% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of research firms have commented on DLB. Barrington Research restated an "outperform" rating and set a $100.00 price target on shares of Dolby Laboratories in a research note on Friday, May 2nd. Rosenblatt Securities reaffirmed a "buy" rating and set a $95.00 price objective on shares of Dolby Laboratories in a report on Friday, August 1st. Wall Street Zen cut Dolby Laboratories from a "buy" rating to a "hold" rating in a report on Saturday, August 9th. Finally, Tigress Financial upped their price target on Dolby Laboratories from $112.00 to $114.00 and gave the stock a "buy" rating in a report on Friday, August 15th. Three analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company currently has an average rating of "Buy" and a consensus price target of $103.00.
Check Out Our Latest Stock Report on DLB
Insider Transactions at Dolby Laboratories
In other Dolby Laboratories news, EVP Mark Andrew Sherman sold 15,000 shares of the company's stock in a transaction dated Wednesday, June 4th. The shares were sold at an average price of $75.02, for a total value of $1,125,300.00. Following the completion of the transaction, the executive vice president directly owned 62,397 shares of the company's stock, valued at $4,681,022.94. This represents a 19.38% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Kevin J. Yeaman sold 39,875 shares of the company's stock in a transaction dated Tuesday, July 15th. The shares were sold at an average price of $74.82, for a total transaction of $2,983,447.50. Following the completion of the transaction, the chief executive officer directly owned 114,725 shares of the company's stock, valued at approximately $8,583,724.50. The trade was a 25.79% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 141,049 shares of company stock valued at $10,521,141. 38.39% of the stock is currently owned by corporate insiders.
Dolby Laboratories Trading Up 3.5%
Shares of NYSE DLB traded up $2.5550 during trading on Friday, reaching $75.3950. The company had a trading volume of 305,940 shares, compared to its average volume of 427,445. Dolby Laboratories has a twelve month low of $68.24 and a twelve month high of $89.66. The stock has a market capitalization of $7.23 billion, a PE ratio of 27.61 and a beta of 0.91. The stock has a 50-day moving average price of $74.29 and a two-hundred day moving average price of $76.72.
Dolby Laboratories (NYSE:DLB - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The electronics maker reported $0.78 EPS for the quarter, topping analysts' consensus estimates of $0.72 by $0.06. The business had revenue of $315.55 million during the quarter, compared to the consensus estimate of $305.23 million. Dolby Laboratories had a return on equity of 11.52% and a net margin of 19.62%.The business's revenue for the quarter was up 9.2% on a year-over-year basis. During the same period in the prior year, the firm posted $0.71 EPS. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. On average, sell-side analysts predict that Dolby Laboratories will post 2.94 EPS for the current year.
Dolby Laboratories Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, August 20th. Shareholders of record on Tuesday, August 12th were given a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date of this dividend was Tuesday, August 12th. Dolby Laboratories's dividend payout ratio is presently 48.35%.
Dolby Laboratories Profile
(
Free Report)
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Further Reading

Before you consider Dolby Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.
While Dolby Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.